- Home
- ASMB vs CDRO Comparison
ASMB vs CDRO Comparison
Compare ASMB & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASMB | CDRO |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | Luxembourg |
| Employees | N/A | 369 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.9M | 421.7M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASMB | CDRO |
|---|---|---|
| Price | $25.50 | $9.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $44.20 | $9.00 |
| AVG Volume (30 Days) | ★ 184.0K | 40.1K |
| Earning Date | 05-06-2026 | 02-28-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | $638.39 | $6.75 |
| P/E Ratio | ★ N/A | $305.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.81 | $5.18 |
| 52 Week High | $39.71 | $10.26 |
Technical Indicators
Market Signals| Indicator | ASMB | CDRO |
|---|---|---|
| Relative Strength Index (RSI) | 50.55 | 46.19 |
| Support Level | $22.49 | $8.46 |
| Resistance Level | $30.80 | $9.61 |
| Average True Range (ATR) | 1.52 | 0.32 |
| MACD | 0.44 | -0.04 |
| Stochastic Oscillator | 59.56 | 2.33 |
Price Performance
Historical ComparisonAbout ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries, where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls, and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.